Patents by Inventor Michael E. Kafrissen

Michael E. Kafrissen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180125860
    Abstract: Compositions and methods for the delivery of progestin hormones that have binding affinity to the Sex Hormone Binding Globulin (SHBG) are disclosed. The compositions combine such progestins with non-progestin SHBG ligands to displace at least part of the progestin from SHBG in the blood plasma, thereby increasing its bioavailability. Also disclosed are methods to modulate progestin and estrogen levels in the blood through the use of SHBG binding and displacement, to optimize the effectiveness of formulations for contraception and minimize the side effects and adverse events.
    Type: Application
    Filed: May 18, 2016
    Publication date: May 10, 2018
    Applicant: Agile Therapeutics, Inc.
    Inventors: Agis Kydonieus, Michael E. Kafrissen, Katie Macfarlane
  • Patent number: 6190693
    Abstract: This invention provides folic acid-containing pharmaceutical compositions comprising either an oral contraceptive or a hormone replacement composition. This invention also provides methods of administering folic acid to a subject using the instant pharmaceutical compositions. Finally, this invention provides a drug delivery system useful for administering the instant pharmaceutical compositions.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: February 20, 2001
    Assignee: Ortho-McNeil Pharamceutical, Inc.
    Inventors: Michael E. Kafrissen, Godfrey Oakley